Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2015
Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CTMarkus Hartenbach, Stefan Weber, Nathalie L Albert, et al.
European Radiology|January 13, 2019
Dynamic [18F]FET-PET/MRI using standard MRI-based attenuation correction methodsIvo Rausch, Andreas Zitterl, Neydher Berroterán-Infante, et al.
Radiology|September 24, 2013
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CTAlexander R Haug, Ramona Cindea-Drimus, Christoph J Auernhammer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2013
Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreasChristine Schmid-Tannwald, Christoph M Schmid-Tannwald, John N Morelli, et al.
European Radiology|June 29, 2013
Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine originWieland H Sommer, Felix Ceelen, Xabier García-Albéniz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 21, 2019
[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid arteryXiang Li, Wei Yu, Tim Wollenweber, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2018
Overall and cause-specific mortality in the Sentinel system: A power analysisRichard S Swain, Lockwood G Taylor, Tiffany S Woodworth, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2022
Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancerAlexander Herold, Christian Wassipaul, Michael Weber, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 22, 2014
Towards new response criteria in neuroendocrine tumors: which changes in MRI parameters are associated with longer progression-free survival after radioembolization of liver metastases?Felix Ceelen, Daniel Theisen, Xabier García de Albéniz, et al.
Pageof 14